Thorsten Waloschek

Thorsten Waloschek is an experienced executive with over 20 years of experience in the medical industry. Thorsten began their career in 2001 as Head of Marketing at Dynamic Synthesis. In 2005, they were promoted to Director of Marketing at Novasep. From 2006 to 2014, they held various roles at Draeger Medical, including President of the Strategic Business Field Neonatal Care & Thermoregulation, Director of Product Management PNC, and Senior Product Manager. In 2012, they became VP Marketing & Sales at ANM Medical GmbH. From 2013 to 2019, they were Owner of CCIAO - MedTech Marketing and Sales Consulting. In 2019, they were Interim Vice President Sales and Marketing at Liberate Medical, LLC. In 2020, they were Interim Chief Executive Officer at BABYBE and Chief Executive Officer at NeoPrediX AG. Thorsten also co-founded InfanDx AG in 2010.

Thorsten Waloschek's education history includes an MBA in International Business from the University of Bradford (1998-2000), a New Medical Device Regulation from Oriel Stat a Matrix (2018), Management Education from Babson College (2009-2011), Management Education from Malik Institute for Management (2008), Management Education from Rutgers University (2007), an Industriekaufmann, Wirtschaftsassistent, Pharmareferent in Economics from IHK Köln (1992-1995), and an Abitur from Schillergymnasium Hannover (1983-1990).